COVID-19 pandemic
Health Canada approves the use of the Pfizer–BioNTech vaccine for children ages 12 to 15, becoming the first country to approve the vaccine for use in younger age groups.
Sources: CTV News
Changes
- Health Canada approves the use of the Pfizer–BioNTech vaccine for children age 12 to 15, becoming the first country to approve the vaccine for use in younger age groups.
- Health Canada approves the use of the Pfizer–BioNTech vaccine for children ages 12 to 15, becoming the first country to approve the vaccine for use in younger age groups.
Related
Indonesia receives their first shipment of 1.56 million doses of the Pfizer–BioNTech vaccine.
The government reaches an agreement with Pfizer for an additional 12 million doses of their vaccine.
President-elect Joe Biden receives a second dose of the Pfizer–BioNTech vaccine on camera.